Treatment of severe psoriasis with biological therapies in patients with viral hepatitis B and C

Br J Dermatol. 2013 Mar;168(3):461-2. doi: 10.1111/bjd.12227.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Dermatologic Agents / adverse effects*
  • Dermatologic Agents / therapeutic use*
  • Female
  • Hepatitis B, Chronic / complications*
  • Hepatitis B, Chronic / etiology*
  • Hepatitis C, Chronic / complications*
  • Humans
  • Immune Reconstitution Inflammatory Syndrome / chemically induced*
  • Male
  • Psoriasis / drug therapy*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*
  • Ustekinumab

Substances

  • Antibodies, Monoclonal, Humanized
  • Dermatologic Agents
  • Tumor Necrosis Factor-alpha
  • Ustekinumab